HIV Flashcards
what are the name of the type of drug that stops binding of the virus to target cell?
fusion inhibitors can stop the binding of the CD4-R/co-receptor (CCR5) to the HIV
protease inhibitors work how?
they stop the action of the viral protease from cleaving proteins into active forms
therefore it stops the virus from getting out of the cell and infecting other cells. it does not however, stop that cell from getting destroyed (c.f. Reverse transc inhibs)
what is the current theory about why patients with HIV get chronic immune activation?
in the initial infection with HIV, there is profound loss of the GALT/peyer’s patches (and this only partially returns even with full treatment)
because of this, there is quite significant loss of the barrier, and then a lot of chronic minor infection, particularly as the bugs are then moved up to the LNs
what is the better predictor of rate of decline of immune function in asymptomatic patient?
HIV RNA concentration or CD4 count?
RNA concentration is better
despite this, markers of immune activation are actually better.
how does the HIV molecule get into the cell?
it binds with the CD4-R. there is a coreceptor which it also needs to bind with
typically this is the CCR5
in patients with specific genetics that lead to loss of CCR5 (e.g. delta32 homozygotes with no CCR5 expression) have resistance to R5 isolates
if delta32 heterozygote, then delated progression to AIDS
what is the treatment regimen of choice for HIV patients?
The optimal antiretroviral (ARV) regimen for a treatment-naive patient consists of two NRTIs in combination with a third active ARV drug from one of three drug classes: an NNRTI, a PI boosted with ritonavir, or an INSTI.
what are some of the agents that you might know about?
let’s talk nucleoside RTIs
Kivexa is a combined tablet
- abacavir and lamivudine
- this agent should not be used in patients with high CVS risk
- 5% of the population will have a hypersens to the abacavir. The way we check for this is the HLAB5701 (if pos, don’t use)
Truvada is a combined tablet
- this is tenofovir plus emtricitabine
- this is the drug of choice for Hep B co-infection (because these agents work against HBV)
what are the nNRTIs of choice?
Nevirapine
- do not use if CD4 counts are above 250 in women, or 400 in men
- this is because with high CD4 counts, it causes an increased risk of hep and rash.
Efavirenz
- popular
- potential teratogenicity
- caution if preggo
PI first line agents?
lopinavir
atazanavir
Each of these should be boosted with ritonavir
- ritonavir works by interacts with CYP-3A4 and leads to decreased hep clearance of other PIs.
- overall it leads to IMPROVED PHARMACOKINETIC PROFILE
what are some mandatory pre-treatment tests in HIV?
- HLA B5701 (abacavir)
- Genotype resistance assay
- Hep B serology
- Pregnancy counselling
- CVD risk calculated
what is the characteristics of the abacavir hypersens reaction?
within the first 6 weeks (usually)
fever rash fatigue malaise sore throat/cough myalgia
N/V/D
if this happens, stop immediately
do not rechallenge, for risk of anaphylactoid
what are some common toxicities seens with ART?
talk about NRTI
lipoatrophy (severe fat wasting) but better described as lipodystrophy because there is some central fat accumulation
MITOCHONDRIAL TOXICITY
peripheral neuropathy
renal disease - particularly tenofovir
zidovudine - N/V/headache/insomnia
what are some common toxicities seens with ART?
talk about nnRTI
rash and hepatitis
CNS toxicity - efavirenz causes this in almost all patients in the first few days of treatment, however it dissipates with time (this is usually nightmares and vivid dreams). Also dizziness (therefore give at night time)
SJ syndrome
what are some common toxicities seens with ART?
talk about PI
Metabolic complications such as hyperlipid and hyperglycaemia
CVS disease - this is ON TOP of the hyperlipid and hypergly (greater than expected for those RFs alone)
diarrhoea
jaundice is particularly common in ATA and IDV (?low yield?)
WHat does rifampicin do to some of the ART?
it decreases the level of PI